| Trial ID: | L5995 |
| Source ID: | NCT01014832
|
| Associated Drug: |
Intensive Insulin Therapy
|
| Title: |
Efficacy and Safety of Frequently Modified Intensive Insulin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: Intensive insulin therapy
|
| Outcome Measures: |
Primary: Hemoglobin A1C, 12 weeks|Mean weekly glucose, 12 weeks|Frequency of hypoglycemia, 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Hygieia, Inc | Collaborators: TKL Research, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-12
|
| Completion Date: |
2009-08
|
| Results First Posted: |
|
| Last Update Posted: |
2009-11-17
|
| Locations: |
TKL Research INC., Paramus, New Jersey, 07652, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01014832
|
